Clinical trial
Feasibility Study of Metformin Therapy in Autosomal Dominant Polycystic Kidney Disease.
NCT02903511 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Feasibility Study of Metformin Therapy in Autosomal Dominant Polycystic Kidney Disease.
- Lead sponsor
- University of Colorado, Denver
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 30, 2016
- Completion date
- August 17, 2020
- Enrollment
- 56 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.